1. Home
  2. GRPN vs RIGL Comparison

GRPN vs RIGL Comparison

Compare GRPN & RIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Groupon Inc.

GRPN

Groupon Inc.

N/A

Current Price

$12.20

Market Cap

1.1B

ML Signal

N/A

Logo Rigel Pharmaceuticals Inc.

RIGL

Rigel Pharmaceuticals Inc.

N/A

Current Price

$45.75

Market Cap

911.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GRPN
RIGL
Founded
2008
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
911.8M
IPO Year
2011
2000

Fundamental Metrics

Financial Performance
Metric
GRPN
RIGL
Price
$12.20
$45.75
Analyst Decision
Buy
Buy
Analyst Count
3
4
Target Price
$25.33
★ $64.40
AVG Volume (30 Days)
★ 1.2M
221.2K
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1867.68
EPS
N/A
★ 1.97
Revenue
★ $2,843,877,000.00
$294,282,000.00
Revenue This Year
$1.72
$3.77
Revenue Next Year
$7.23
$19.69
P/E Ratio
★ N/A
$22.55
Revenue Growth
N/A
★ 64.15
52 Week Low
$9.17
$24.84
52 Week High
$29.90
$52.61

Technical Indicators

Market Signals
Indicator
GRPN
RIGL
Relative Strength Index (RSI) 30.53 47.05
Support Level $11.86 $44.83
Resistance Level $13.80 $51.00
Average True Range (ATR) 1.09 2.54
MACD -0.31 -0.63
Stochastic Oscillator 8.86 54.72

Price Performance

Historical Comparison
GRPN
RIGL

About GRPN Groupon Inc.

Groupon Inc is a globalised, scaled two-sided marketplace that connects consumers to merchants. Its categories include Local: local inventory includes things to do, beauty and wellness, food and drink, home and automotive services, online services, as well as other types of experiences and services. Goods: Includes merchandise across multiple product lines, such as electronics, sporting goods, jewelry, toys, household items and apparel, and Travel: Features travel experiences at both discounted and market rates, including hotels, airfare, and package deals covering both domestic and international travel. The company operates in two segments, North America and International, with the majority of revenue from the Local category from the North America Segment.

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, REZLIDHIA (olutasidenib), GAVRETO (pralsetinib), R289, and Ocadusertib (Systemic) - Eli Lilly.

Share on Social Networks: